A potential $3 billion injection from the Export-Import Bank of the United States could soon anchor a massive aerospace manufacturing campus in Greensboro, North Carolina. JetZero signed a letter of interest at the Farnborough International Airshow, signaling a major push to scale domestic production capacity for next-generation aircraft.
In Korla, Xinjiang, the China National Petroleum Corporation has activated the Tarim 1.2 MTA Phase II Ethylene Project, the nation’s first petrochemical site to integrate green energy and carbon capture across its entire production chain, signaling a major shift toward industrial decarbonization in the region.
The global omega-3 market is poised for significant expansion, with projections indicating growth from $4.88 billion in 2026 to $8.73 billion by 2031. Driven by a compound annual growth rate of 12.3%, the sector is seeing increased demand as consumers prioritize cardiovascular, cognitive, and joint health through targeted supplementation.
As the Castle Preservation Society marks its 20th anniversary, the Moultonborough historic site has appointed Kayla Szczesiul as its new Director of Advancement. Szczesiul brings nearly two decades of nonprofit expertise to oversee the organization's fundraising, marketing, and community outreach efforts during this new institutional chapter.
Under the flight line at the Farnborough International Airshow, Trakka Systems is putting its integrated mission ecosystem to the test. Through July 24, the company is hosting live demonstrations of its flagship imaging and mapping technology, aiming to prove how high-definition sensor data translates into real-world tactical awareness.
With nearly 2 million vehicles already registered in Shaoxing, the Yangtze River Delta has become the latest frontier for Uxin’s expansion. The Nasdaq-listed retailer is planting a new superstore in the city, aiming to capture a market fueled by a population of 5 million and a robust private sector.
Investors who purchased BitGo Holdings stock following the company's January 22, 2026, initial public offering face a looming August 7 deadline to join a class action lawsuit. The litigation alleges that the firm misled shareholders regarding its financial health and exposure to volatile digital asset markets.
Investors who purchased Badger Meter shares between April 18, 2024, and April 16, 2026, are being urged to join a class action lawsuit. The DJS Law Group alleges the company misrepresented its growth, masking a reliance on pulled-forward orders behind claims of solid operational execution and secular performance drivers.
Investors who purchased BitGo Holdings securities during its January 2026 initial public offering or the following months may now join a federal class action lawsuit. The Schall Law Firm alleges the company misled shareholders by downplaying the risks of volatile digital asset prices while promoting its financial outlook.
Investors who held Black Rock Coffee Bar shares between September 12, 2025, and May 12, 2026, face a critical deadline as a class action lawsuit accuses the company of misleading the market regarding its expansion strategy and the impact of new store openings on existing revenue streams.
Investors who purchased Calix, Inc. securities between January 28 and April 21, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on claims that the company misled the market regarding margin stability and the procurement costs of memory components.
A class action lawsuit has been filed against Calix, Inc. in Los Angeles, alleging the company misled shareholders regarding its financial health. The litigation centers on claims that the telecommunications firm concealed how aggressive memory module purchases temporarily inflated performance, masking underlying margin pressures during early 2026.
Lundbeck has finalized randomization for the DEEp OCEAN Phase III clinical trial, a global study evaluating the investigational drug bexicaserin. The trial targets developmental and epileptic encephalopathies, a diverse group of severe childhood-onset epilepsies that currently lack comprehensive treatment options for many of the various underlying genetic syndromes.
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, face a July 27 deadline to join a class action lawsuit. The litigation alleges the pharmaceutical company misled shareholders regarding the performance and safety of its key veterinary products, including Librela, Apoquel, and Cytopoint.
Lundbeck has finalized patient randomization for DEEp OCEAN, a pivotal Phase III clinical trial testing the investigational molecule bexicaserin. The study targets a wide spectrum of developmental and epileptic encephalopathies, marking a significant step toward addressing a group of severe childhood-onset conditions that currently lack universal treatment options.
Eighty-five years after the American Volunteer Group first took to the skies over China, a new initiative has launched in Nanjing to locate the remains of missing pilots. The project aims to cross-reference international archives to finally identify airmen lost during the fight against fascism in World War II.
Investors who purchased Planet Fitness shares between November 6, 2025, and May 6, 2026, are being urged to join a class action lawsuit against the company. The litigation alleges that the fitness chain violated federal securities laws by issuing false and misleading statements regarding its growth and pricing strategies.
Under the backdrop of the 2026 Farnborough International Airshow, Acron Technologies officially unveiled a consolidated corporate identity. The launch marks the first public pivot for the platform, which integrates thirteen specialized aerospace and defense firms into a single, cohesive portfolio designed to streamline mission-critical technology services.
The Schall Law Firm has launched an investigation into Alibaba Group Holding Limited following allegations that the e-commerce giant illicitly misappropriated core technology from the U.S.-based artificial intelligence company Anthropic, potentially misleading shareholders regarding the integrity of its proprietary systems.
Investors who held ADMA Biologics stock between August 9, 2024, and March 25, 2026, face a critical deadline as a class action lawsuit moves forward. The DJS Law Group is currently organizing plaintiffs to address allegations that the pharmaceutical company misled the market regarding its financial practices and internal transactions.
Investors who purchased AeroVironment, Inc. shares between June 25, 2025, and March 10, 2026, face a July 27, 2026, deadline to join a class action lawsuit. The litigation targets the company for allegedly concealing the true extent of competition regarding U.S. Space Force contracts.
A national shareholder rights firm is organizing a class action against Badger Meter, Inc., alleging the company misled investors by inflating financial performance through the premature recognition of customer orders between April 2024 and April 2026.
Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, face a critical deadline as the Schall Law Firm organizes a class action lawsuit. The litigation targets alleged misrepresentations regarding competitive pressures surrounding the company’s U.S. Space Force satellite communication contracts.
The BC token reached an all-time high of approximately $0.0179 on July 20, marking a 14% surge since its previous peak just three days earlier. This latest price record underscores a steady climb for the BC.GAME ecosystem asset, which has gained over 50% in value since mid-April.
German patients requiring higher daily insulin doses will soon gain access to Medtrum’s 300U tubeless patch pump. Following a debut at the DDG 2026 conference in Berlin, the device secured a dedicated product code in the national statutory health insurance directory, clearing a critical path for reimbursement and commercial distribution.
Between July 13 and July 17, 2026, Ericsson repurchased 9,595,000 of its own Class B shares, deploying nearly 945 million Swedish kronor. The aggressive buying spree, executed via Goldman Sachs Bank Europe SE on Nasdaq Stockholm, marks a significant step in the company's 15 billion kronor capital return program.
South Korean manufacturer Shinsung Materials has secured a patent for the purification and stabilization of Ecamsule, a high-performance UV-A filter. By refining Terephthalylidene Dicamphor Sulfonic Acid into a high-purity powder, the company is addressing long-standing formulation challenges that previously hindered the ingredient's broader use in global sun care products.
Between July 13 and July 17, 2026, Ericsson repurchased 9,595,000 of its own Class B shares, committing a total of 944.88 million SEK to the effort. The acquisitions, executed on Nasdaq Stockholm by Goldman Sachs Bank Europe SE, mark a significant acceleration in the company’s ongoing capital allocation strategy.
Investors who held Regeneron Pharmaceuticals stock between August 1, 2025, and May 15, 2026, are being urged to join a class action lawsuit following claims that the company misled the market regarding the efficacy of its Phase III Fianlimab-Libtayo study.
Antengene Corporation will showcase new clinical findings for its lead oncology candidates during the European Society for Medical Oncology Annual Congress in Madrid this October. The presentations cover Phase 2 results for a Claudin 18.2 antibody-drug conjugate and updated data on a small-molecule inhibitor for resistant melanoma.
